-
2
-
-
0033918032
-
Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent
-
Zomas A, Anagnostopoulos N, Dimopoulos MA: Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent. Bone Marrow Transplant 25:1319-1320, 2000 (Pubitemid 30428151)
-
(2000)
Bone Marrow Transplantation
, vol.25
, Issue.12
, pp. 1319-1320
-
-
Zomas, A.1
Anagnostopoulos, N.2
Dimopoulos, M.A.3
-
3
-
-
2942748363
-
Thalidomide sensory neurotoxicity: A clinical and neurophysiologic study
-
Cavaletti G, Beronio A, Reni L, et al: Thalidomide sensory neurotoxicity: A clinical and neurophysiologic study. Neurology 62:2291-2293, 2004 (Pubitemid 38787791)
-
(2004)
Neurology
, vol.62
, Issue.12
, pp. 2291-2293
-
-
Cavaletti, G.1
Beronio, A.2
Reni, L.3
Ghiglione, E.4
Schenone, A.5
Briani, C.6
Zara, G.7
Cocito, D.8
Isoardo, G.9
Ciaramitaro, P.10
Plasmati, R.11
Pastorelli, F.12
Frigo, M.13
Piatti, M.14
Carpo, M.15
-
4
-
-
33751094293
-
The troublesome toxicity of peripheral neuropathy with thalidomide
-
DOI 10.1080/10428190600948303, PII M867836022V65854
-
Mileshkin L, Prince HM: The troublesome toxicity of peripheral neuropathy with thalidomide. Leuk Lymphoma 47:2276-2279, 2006 (Pubitemid 44768418)
-
(2006)
Leukemia and Lymphoma
, vol.47
, Issue.11
, pp. 2276-2279
-
-
Mileshkin, L.1
Prince, H.M.2
-
5
-
-
10744220458
-
Thalidomide neuropathy: Clinical, electrophysiological and neuroradiological features
-
DOI 10.1034/j.1600-0404.2003.00203.x
-
Isoardo G, Bergui M, Durelli L, et al: Thalidomide neuropathy: Clinical, electrophysiological and neuroradiological features. Acta Neurol Scand 109:188-193, 2004 (Pubitemid 38270874)
-
(2004)
Acta Neurologica Scandinavica
, vol.109
, Issue.3
, pp. 188-193
-
-
Isoardo, G.1
Bergui, M.2
Durelli, L.3
Barbero, P.4
Boccadoro, M.5
Bertola, A.6
Ciaramitaro, P.7
Palumbo, A.8
Bergamasco, B.9
Cocito, D.10
-
6
-
-
2942729733
-
Thalidomide neurotoxicity: Prospective study in patients with lupus erythematosus
-
Briani C, Zara G, Rondinone R, et al: Thalidomide neurotoxicity: Prospective study in patients with lupus erythematosus. Neurology 62:2288-2290, 2004 (Pubitemid 38787790)
-
(2004)
Neurology
, vol.62
, Issue.12
, pp. 2288-2290
-
-
Briani, C.1
Zara, G.2
Rondinone, R.3
Della, L.S.4
Ermani, M.5
Ruggero, S.6
Ghirardello, A.7
Zampieri, S.8
Doria, A.9
-
7
-
-
0029758257
-
Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses
-
DOI 10.1016/S0190-9622(96)90122-X
-
Tseng S, Pak G, Washenik K, et al: Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol 35:969-979, 1996 (Pubitemid 26422122)
-
(1996)
Journal of the American Academy of Dermatology
, vol.35
, Issue.6
, pp. 969-979
-
-
Tseng, S.1
Pak, G.2
Washenik, K.3
Pomeranz, M.K.4
Shupack, J.L.5
-
8
-
-
0005185331
-
Low serum vitamin B12 in patients with plasma cell myeloma is associated with plasma cell myeloma with true functional cobalamin deficiency
-
Beckmann MJ, Hussein MA, Lichtin A, et al: Low serum vitamin B12 in patients with plasma cell myeloma is associated with plasma cell myeloma with true functional cobalamin deficiency. Am J Clin Pathol 140:350, 1995
-
(1995)
Am J Clin Pathol
, vol.140
, pp. 350
-
-
Beckmann, M.J.1
Hussein, M.A.2
Lichtin, A.3
-
9
-
-
0034745883
-
Thalomid (thalidomide) capsules: A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing
-
Clark TE, Edom N, Larson J, et al: Thalomid (thalidomide) capsules: A review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing. Drug Saf 24:87-117, 2001
-
(2001)
Drug Saf
, vol.24
, pp. 87-117
-
-
Clark, T.E.1
Edom, N.2
Larson, J.3
-
10
-
-
12244249165
-
Thalidomide-induced neuropathy: A ganglionopathy?
-
Giannini F, Volpi N, Rossi S, et al: Thalidomide-induced neuropathy: A ganglionopathy? Neurology 60:877-878, 2003
-
(2003)
Neurology
, vol.60
, pp. 877-878
-
-
Giannini, F.1
Volpi, N.2
Rossi, S.3
-
11
-
-
0343628805
-
Thalidomide neuropathy: Role of F-wave monitoring
-
DOI 10.1002/1097-4598(200008)23:8<1301::AID-MUS25>3.0.CO;2-4
-
Rao DG, Kane NM, Oware A: Thalidomide neuropathy: Role of F-wave monitoring. Muscle Nerve 23:1301-1302, 2000 (Pubitemid 30602257)
-
(2000)
Muscle and Nerve
, vol.23
, Issue.8
, pp. 1301-1302
-
-
Ganesh, R.D.1
Kane, N.M.2
Oware, A.3
-
12
-
-
0022649529
-
Thalidomide-induced peripheral neuropathy. A prospective clinical, neurophysiological and pharmacogenetic evaluation
-
Hess CW, Hunziker T, Küpfer A, et al: Thalidomide-induced peripheral neuropathy: A prospective clinical, neurophysiological and pharmacogenetic evaluation. J Neurol 233:83-89, 1986 (Pubitemid 16125225)
-
(1986)
Journal of Neurology
, vol.233
, Issue.2
, pp. 83-89
-
-
Hess, C.W.1
Hunziker, T.2
Kupfer, A.3
Ludin, H.P.4
-
13
-
-
0028879821
-
Thalidomide-induced neuropathy and genetic differences in drug metabolism
-
Harland CC, Steventon GB, Marsden JR: Thalidomide-induced neuropathy and genetic differences in drug metabolism. Eur J Clin Pharmacol 49:1-6, 1995
-
(1995)
Eur J Clin Pharmacol
, vol.49
, pp. 1-6
-
-
Harland, C.C.1
Steventon, G.B.2
Marsden, J.R.3
-
14
-
-
52449099461
-
Genomic variation in myeloma: Design, content, and initial application of the Bank on A Cure SNP Panel to detect associations with progression-free survival
-
Van Ness B, Ramos C, Haznadar M, et al: Genomic variation in myeloma: Design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. BMC Med 6:26, 2008
-
(2008)
BMC Med
, vol.6
, pp. 26
-
-
Van Ness, B.1
Ramos, C.2
Haznadar, M.3
-
15
-
-
58149380751
-
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping
-
Johnson DC, Corthals S, Ramos C, et al: Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood 112:4924-4934, 2008
-
(2008)
Blood
, vol.112
, pp. 4924-4934
-
-
Johnson, D.C.1
Corthals, S.2
Ramos, C.3
-
16
-
-
70350092339
-
Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma
-
Durie BG, Van Ness B, Ramos C, et al: Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma. Leukemia 23:1913-1919, 2009
-
(2009)
Leukemia
, vol.23
, pp. 1913-1919
-
-
Durie, B.G.1
Van Ness, B.2
Ramos, C.3
-
17
-
-
34548292504
-
PLINK: A tool set for whole-genome association and population-based linkage analyses
-
DOI 10.1086/519795
-
Purcell S, Neale B, Todd-Brown K, et al: PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575, 2007 (Pubitemid 47330214)
-
(2007)
American Journal of Human Genetics
, vol.81
, Issue.3
, pp. 559-575
-
-
Purcell, S.1
Neale, B.2
Todd-Brown, K.3
Thomas, L.4
Ferreira, M.A.R.5
Bender, D.6
Maller, J.7
Sklar, P.8
De Bakker, P.I.W.9
Daly, M.J.10
Sham, P.C.11
-
18
-
-
0038005018
-
DAVID: Database for Annotation, Visualization, and Integrated Discovery
-
Dennis G Jr, Sherman BT, Hosack DA, et al: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:P3, 2003
-
(2003)
Genome Biol
, vol.4
, pp. 3
-
-
Dennis Jr., G.1
Sherman, B.T.2
Hosack, D.A.3
-
19
-
-
11144358198
-
A gene atlas of the mouse and human protein-encoding transcriptomes
-
DOI 10.1073/pnas.0400782101
-
Su AI, Wiltshire T, Batalov S, et al: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101:6062-6067, 2004 (Pubitemid 38520528)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.16
, pp. 6062-6067
-
-
Su, A.I.1
Wiltshire, T.2
Batalov, S.3
Lapp, H.4
Ching, K.A.5
Block, D.6
Zhang, J.7
Soden, R.8
Hayakawa, M.9
Kreiman, G.10
Cooke, M.P.11
Walker, J.R.12
Hogenesch, J.B.13
-
20
-
-
33748190743
-
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma
-
DOI 10.1182/blood-2006-02-005496
-
Walker BA, Leone PE, Jenner MW, et al: Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood 108:1733-1743, 2006 (Pubitemid 44316144)
-
(2006)
Blood
, vol.108
, Issue.5
, pp. 1733-1743
-
-
Walker, B.A.1
Leone, P.E.2
Jenner, M.W.3
Li, C.4
Gonzalez, D.5
Johnson, D.C.6
Ross, F.M.7
Davies, F.E.8
Morgan, G.J.9
-
21
-
-
27644482314
-
Mapping determinants of human gene expression by regional and genome-wide association
-
DOI 10.1038/nature04244, PII N04244
-
Cheung VG, Spielman RS, Ewens KG, et al: Mapping determinants of human gene expression by regional and genome-wide association. Nature 437:1365-1369, 2005 (Pubitemid 41568683)
-
(2005)
Nature
, vol.437
, Issue.7063
, pp. 1365-1369
-
-
Cheung, V.G.1
Spielman, R.S.2
Ewens, K.G.3
Weber, T.M.4
Morley, M.5
Burdick, J.T.6
-
22
-
-
65849256988
-
Willows: A memory efficient tree and forest construction package
-
Zhang H, Wang M, Chen X: Willows: A memory efficient tree and forest construction package. BMC Bioinformatics 10:130, 2009
-
(2009)
BMC Bioinformatics
, vol.10
, pp. 130
-
-
Zhang, H.1
Wang, M.2
Chen, X.3
-
23
-
-
0036517472
-
A comprehensive review of genetic association studies
-
Hirschhorn JN, Lohmueller K, Byrne E, et al: A comprehensive review of genetic association studies. Genet Med 4:45-61, 2002
-
(2002)
Genet Med
, vol.4
, pp. 45-61
-
-
Hirschhorn, J.N.1
Lohmueller, K.2
Byrne, E.3
-
24
-
-
77949756362
-
Genome-wide association studies in pharmacogenomics
-
Daly AK: Genome-wide association studies in pharmacogenomics. Nat Rev Genet 11:241-246, 2010
-
(2010)
Nat Rev Genet
, vol.11
, pp. 241-246
-
-
Daly, A.K.1
-
25
-
-
33847249931
-
Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex
-
DOI 10.1038/sj.tpj.6500403, PII 6500403
-
Haenisch S, Zimmermann U, Dazert E, et al: Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. Pharmacogenomics J 7:56-65, 2007 (Pubitemid 46322080)
-
(2007)
Pharmacogenomics Journal
, vol.7
, Issue.1
, pp. 56-65
-
-
Haenisch, S.1
Zimmermann, U.2
Dazert, E.3
Wruck, C.J.4
Dazert, P.5
Siegmund, S.6
Kroemer, H.K.7
Warzok, R.W.8
Cascorbi, I.9
-
26
-
-
3543004158
-
Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2
-
DOI 10.1023/B:PHAM.0000026422.06207.33
-
Hirouchi M, Suzuki H, Itoda M, et al: Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2. Pharm Res 21:742-748, 2004 (Pubitemid 39011294)
-
(2004)
Pharmaceutical Research
, vol.21
, Issue.5
, pp. 742-748
-
-
Hirouchi, M.1
Suzuki, H.2
Itoda, M.3
Ozawa, S.4
Sawada, J.-I.5
Ieiri, I.6
Ohtsubo, K.7
Sugiyama, Y.8
-
27
-
-
0036206860
-
Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: An association between single nucleotide polymorphisms in the 5′-untranslated region and exon 28
-
DOI 10.1124/dmd.30.4.363
-
Itoda M, Saito Y, Soyama A, et al: Polymorphisms in the ABCC2 (cMOAT/MRP2) gene found in 72 established cell lines derived from Japanese individuals: An association between single nucleotide polymorphisms in the 5′-untranslated region and exon 28. Drug Metab Dispos 30:363-364, 2002 (Pubitemid 34263818)
-
(2002)
Drug Metabolism and Disposition
, vol.30
, Issue.4
, pp. 363-364
-
-
Itoda, M.1
Saito, Y.2
Soyama, A.3
Saeki, M.4
Murayama, N.5
Ishida, S.6
Sai, K.7
Nagano, M.8
Suzuki, H.9
Sugiyama, Y.10
Ozawa, S.11
Sawada, J.-I.12
-
28
-
-
34248547635
-
MRP2 haplotypes confer differential susceptibility to toxic liver injury
-
DOI 10.1097/01.fpc.0000236337.41799.b3, PII 0121301120070600000003
-
Choi JH, Ahn BM, Yi J, et al: MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet Genomics 17:403-415, 2007 (Pubitemid 46763385)
-
(2007)
Pharmacogenetics and Genomics
, vol.17
, Issue.6
, pp. 403-415
-
-
Choi, J.H.1
Ahn, B.M.2
Yi, J.3
Lee, J.H.4
Lee, J.H.5
Nam, S.W.6
Chon, C.Y.7
Han, K.-H.8
Ahn, S.H.9
Jang, I.-J.10
Cho, J.-Y.11
Suh, Y.12
Cho, M.-O.13
Lee, J.-E.14
Kim, K.H.15
Lee, M.G.16
-
29
-
-
33846504706
-
A "silent" polymorphism in the MDR1 gene changes substrate specificity
-
Kimchi-Sarfaty C, Oh JM, Kim IW, et al: A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315:525-528, 2007
-
(2007)
Science
, vol.315
, pp. 525-528
-
-
Kimchi-Sarfaty, C.1
Oh, J.M.2
Kim, I.W.3
-
30
-
-
51649129871
-
ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel
-
Sissung TM, Baum CE, Deeken J, et al: ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel. Clin Cancer Res 14:4543-4549, 2008
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4543-4549
-
-
Sissung, T.M.1
Baum, C.E.2
Deeken, J.3
-
31
-
-
33751044628
-
Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia
-
DOI 10.1016/j.ejca.2006.06.017, PII S0959804906006009
-
Sissung TM, Mross K, Steinberg SM, et al: Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia. Eur J Cancer 42:2893-2896, 2006 (Pubitemid 44755257)
-
(2006)
European Journal of Cancer
, vol.42
, Issue.17
, pp. 2893-2896
-
-
Sissung, T.M.1
Mross, K.2
Steinberg, S.M.3
Behringer, D.4
Figg, W.D.5
Sparreboom, A.6
Mielke, S.7
-
32
-
-
33749028208
-
A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor
-
Yang XX, Hu ZP, Xu AL, et al: A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor. J Pharmacol Exp Ther 319:82-104, 2006
-
(2006)
J Pharmacol Exp Ther
, vol.319
, pp. 82-104
-
-
Yang, X.X.1
Hu, Z.P.2
Xu, A.L.3
-
33
-
-
0036843702
-
The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum
-
DOI 10.1038/ng1002
-
Howard HC, Mount DB, Rochefort D, et al: The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet 32:384-392, 2002 (Pubitemid 35266112)
-
(2002)
Nature Genetics
, vol.32
, Issue.3
, pp. 384-392
-
-
Howard, H.C.1
Mount, D.B.2
Rochefort, D.3
Byun, N.4
Dupre, N.5
Lu, J.6
Fan, X.7
Song, L.8
Riviere, J.-B.9
Prevost, C.10
Horst, J.11
Simonati, A.12
Lemcke, B.13
Welch, R.14
England, R.15
Zhan, F.Q.16
Mercado, A.17
Siesser, W.B.18
George Jr., A.L.19
McDonald, M.P.20
Bouchard, J.-P.21
Mathieu, J.22
Delpire, E.23
Rouleau, G.A.24
more..
-
34
-
-
0037974540
-
Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomide
-
Ando Y, Price DK, Dahut WL, et al: Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomide. Cancer Biol Ther 1:669-673, 2002
-
(2002)
Cancer Biol Ther
, vol.1
, pp. 669-673
-
-
Ando, Y.1
Price, D.K.2
Dahut, W.L.3
-
35
-
-
0036285336
-
Thalidomide metabolism by the CYP2C subfamily
-
Ando Y, Fuse E, Figg WD: Thalidomide metabolism by the CYP2C subfamily. Clin Cancer Res 8:1964-1973, 2002
-
(2002)
Clin Cancer Res
, vol.8
, pp. 1964-1973
-
-
Ando, Y.1
Fuse, E.2
Figg, W.D.3
-
36
-
-
36348965389
-
Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide-based regimens in multiple myeloma
-
DOI 10.3324/haematol.11319
-
Li Y, Hou J, Jiang H, et al: Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide based regimens in multiple myeloma. Haematologica 92:1246-1249, 2007 (Pubitemid 350144185)
-
(2007)
Haematologica
, vol.92
, Issue.9
, pp. 1246-1249
-
-
Li, Y.1
Hou, J.2
Jiang, H.3
Wang, D.4
Fu, W.5
Yuan, Z.6
Chen, Y.7
Zhou, L.8
-
37
-
-
3342996710
-
Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans
-
DOI 10.1124/jpet.104.067793
-
Lu J, Helsby N, Palmer BD, et al: Metabolism of thalidomide in liver microsomes of mice, rabbits, and humans. J Pharmacol Exp Ther 310:571-577, 2004 (Pubitemid 38988901)
-
(2004)
Journal of Pharmacology and Experimental Therapeutics
, vol.310
, Issue.2
, pp. 571-577
-
-
Lu, J.1
Helsby, N.2
Palmer, B.D.3
Tingle, M.4
Baguley, B.C.5
Kestell, P.6
Ching, L.-M.7
-
38
-
-
0037083631
-
Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth
-
Bonilla IE, Tanabe K, Strittmatter SM: Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci 22:1303-1315, 2002 (Pubitemid 34163732)
-
(2002)
Journal of Neuroscience
, vol.22
, Issue.4
, pp. 1303-1315
-
-
Bonilla, I.E.1
Tanabe, K.2
Strittmatter, S.M.3
-
39
-
-
15044339715
-
Induction of plasminogen activator inhibitor-1 and -2 in dorsal root ganglion neurons after peripheral nerve injury
-
DOI 10.1016/j.neuroscience.2004.12.003
-
Yamanaka H, Obata K, Fukuoka T, et al: Induction of plasminogen activator inhibitor-1 and -2 in dorsal root ganglion neurons after peripheral nerve injury. Neuroscience 132:183-191, 2005 (Pubitemid 40380725)
-
(2005)
Neuroscience
, vol.132
, Issue.1
, pp. 183-191
-
-
Yamanaka, H.1
Obata, K.2
Fukuoka, T.3
Dai, Y.4
Kobayashi, K.5
Tokunaga, A.6
Noguchi, K.7
-
40
-
-
67650698311
-
A pharmacokinetic study evaluating the relationship between treatment efficacy and incidence of adverse events with thalidomide plasma concentrations in patients with refractory multiple myeloma
-
Kodama T, Abe M, Iida S, et al: A pharmacokinetic study evaluating the relationship between treatment efficacy and incidence of adverse events with thalidomide plasma concentrations in patients with refractory multiple myeloma. Clin Lymphoma Myeloma 9:154-159, 2009
-
(2009)
Clin Lymphoma Myeloma
, vol.9
, pp. 154-159
-
-
Kodama, T.1
Abe, M.2
Iida, S.3
-
42
-
-
33845890019
-
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study
-
DOI 10.1007/s10637-006-9010-y
-
von Delius S, Eckel F, Wagenpfeil S, et al: Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II study. Invest New Drugs 25:173-180, 2007 (Pubitemid 46020877)
-
(2007)
Investigational New Drugs
, vol.25
, Issue.2
, pp. 173-180
-
-
Von Delius, S.1
Eckel, F.2
Wagenpfeil, S.3
Mayr, M.4
Stock, K.5
Kullmann, F.6
Obermeier, F.7
Erdmann, J.8
Schmelz, R.9
Quasthoff, S.10
Adelsberger, H.11
Bredenkamp, R.12
Schmid, R.M.13
Lersch, C.14
|